273 related articles for article (PubMed ID: 34008894)
1. Sphingosine-1-Phosphate, Motor Severity, and Progression in Parkinson's Disease (MARK-PD).
Schwedhelm E; Englisch C; Niemann L; Lezius S; von Lucadou M; Marmann K; Böger R; Peine S; Daum G; Gerloff C; Choe CU
Mov Disord; 2021 Sep; 36(9):2178-2182. PubMed ID: 34008894
[TBL] [Abstract][Full Text] [Related]
2. Serum neurofilament is associated with motor function, cognitive decline and subclinical cardiac damage in advanced Parkinson's disease (MARK-PD).
Niemann L; Lezius S; Maceski A; Leppert D; Englisch C; Schwedhelm E; Zeller T; Gerloff C; Kuhle J; Choe CU
Parkinsonism Relat Disord; 2021 Sep; 90():44-48. PubMed ID: 34352610
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes of deep brain stimulation in severe Parkinson's disease utilizing UPDRS III and modified Hoehn and Yahr as a severity scale.
Kahn L; Mathkour M; Lee SX; Gouveia EE; Hanna JA; Garces J; Scullen T; McCormack E; Riffle J; Glynn R; Houghton D; Lea G; Biro EE; Bui CJ; Sulaiman OA; Smith RD
Clin Neurol Neurosurg; 2019 Apr; 179():67-73. PubMed ID: 30851616
[TBL] [Abstract][Full Text] [Related]
4. Diabetes, Glycated Hemoglobin (HbA1c), and Neuroaxonal Damage in Parkinson's Disease (MARK-PD Study).
Uyar M; Lezius S; Buhmann C; Pötter-Nerger M; Schulz R; Meier S; Gerloff C; Kuhle J; Choe CU
Mov Disord; 2022 Jun; 37(6):1299-1304. PubMed ID: 35384057
[TBL] [Abstract][Full Text] [Related]
5. Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort.
Regnault A; Boroojerdi B; Meunier J; Bani M; Morel T; Cano S
J Neurol; 2019 Aug; 266(8):1927-1936. PubMed ID: 31073716
[TBL] [Abstract][Full Text] [Related]
6. The Emergence and Progression of Motor Dysfunction in Individuals at Risk of Parkinson's Disease.
Simonet C; Mahlknecht P; Marini K; Seppi K; Gill A; Bestwick JP; Lees AJ; Giovannoni G; Schrag A; Noyce AJ
Mov Disord; 2023 Sep; 38(9):1636-1644. PubMed ID: 37317903
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and relative factors of constipation in a cohort of Chinese patients with Parkinson's disease.
Sun BH; Wang T; Li NY; Wu Q; Qiao J
World J Gastrointest Pharmacol Ther; 2021 Jan; 12(1):21-31. PubMed ID: 33564494
[TBL] [Abstract][Full Text] [Related]
8. Plasma glial fibrillary acidic protein as a biomarker of disease progression in Parkinson's disease: a prospective cohort study.
Lin J; Ou R; Li C; Hou Y; Zhang L; Wei Q; Pang D; Liu K; Jiang Q; Yang T; Xiao Y; Zhao B; Chen X; Song W; Yang J; Wu Y; Shang H
BMC Med; 2023 Nov; 21(1):420. PubMed ID: 37932720
[TBL] [Abstract][Full Text] [Related]
9. Urate and Homocysteine: Predicting Motor and Cognitive Changes in Newly Diagnosed Parkinson's Disease.
Sleeman I; Lawson RA; Yarnall AJ; Duncan GW; Johnston F; Khoo TK; Burn DJ
J Parkinsons Dis; 2019; 9(2):351-359. PubMed ID: 30909247
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Rotigotine at Different Stages of Parkinson's Disease Symptom Severity and Disability: A Post Hoc Analysis According to Baseline Hoehn and Yahr Stage.
Giladi N; Nicholas AP; Asgharnejad M; Dohin E; Woltering F; Bauer L; Poewe W
J Parkinsons Dis; 2016 Oct; 6(4):741-749. PubMed ID: 27567886
[TBL] [Abstract][Full Text] [Related]
11. Serum uric acid levels and freezing of gait in Parkinson's disease.
Ou R; Cao B; Wei Q; Hou Y; Xu Y; Song W; Zhao B; Shang H
Neurol Sci; 2017 Jun; 38(6):955-960. PubMed ID: 28251464
[TBL] [Abstract][Full Text] [Related]
12. The association between Parkinson's disease symptom side-of-onset and performance on the MDS-UPDRS scale part IV: Motor complications.
Bay AA; Hart AR; Michael Caudle W; Corcos DM; Hackney ME
J Neurol Sci; 2019 Jan; 396():262-265. PubMed ID: 30537631
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Mini-Mental State Examination and Montreal Cognitive Assessment Ratings Across Levels of Parkinson's Disease Severity.
Snyder A; Gruber-Baldini AL; Rainer von Coelln F; Savitt JM; Reich SG; Armstrong MJ; Shulman LM
J Parkinsons Dis; 2021; 11(4):1995-2003. PubMed ID: 34366371
[TBL] [Abstract][Full Text] [Related]
14. Digital Mobility Measures: A Window into Real-World Severity and Progression of Parkinson's Disease.
Mirelman A; Volkov J; Salomon A; Gazit E; Nieuwboer A; Rochester L; Del Din S; Avanzino L; Pelosin E; Bloem BR; Della Croce U; Cereatti A; Thaler A; Roggen D; Mazza C; Shirvan J; Cedarbaum JM; Giladi N; Hausdorff JM
Mov Disord; 2024 Feb; 39(2):328-338. PubMed ID: 38151859
[TBL] [Abstract][Full Text] [Related]
15. Association of lipid levels with motor and cognitive function and decline in advanced Parkinson's disease in the Mark-PD study.
Choe CU; Petersen E; Lezius S; Cheng B; Schulz R; Buhmann C; Pötter-Nerger M; Daum G; Blankenberg S; Gerloff C; Schwedhelm E; Zeller T
Parkinsonism Relat Disord; 2021 Apr; 85():5-10. PubMed ID: 33636481
[TBL] [Abstract][Full Text] [Related]
16. Corneal Confocal Microscopy Identifies Parkinson's Disease with More Rapid Motor Progression.
Lim SH; Ferdousi M; Kalteniece A; Mahfoud ZR; Petropoulos IN; Malik RA; Kobylecki C; Silverdale M
Mov Disord; 2021 Aug; 36(8):1927-1934. PubMed ID: 33826165
[TBL] [Abstract][Full Text] [Related]
17. The semicircular canal function is preserved with little impact on falls in patients with mild Parkinson's disease.
Hong JP; Kwon H; Park E; Lee SU; Lee CN; Kim BJ; Kim JS; Park KW
Parkinsonism Relat Disord; 2024 Jan; 118():105933. PubMed ID: 38007917
[TBL] [Abstract][Full Text] [Related]
18. Self-Report versus Clinician Examination in Early Parkinson's Disease.
Zolfaghari S; Thomann AE; Lewandowski N; Trundell D; Lipsmeier F; Pagano G; Taylor KI; Postuma RB
Mov Disord; 2022 Mar; 37(3):585-597. PubMed ID: 34897818
[TBL] [Abstract][Full Text] [Related]
19. Examining the Reserve Hypothesis in Parkinson's Disease: A Longitudinal Study.
Lee PC; Artaud F; Cormier-Dequaire F; Rascol O; Durif F; Derkinderen P; Marques AR; Bourdain F; Brandel JP; Pico F; Lacomblez L; Bonnet C; Brefel-Courbon C; Ory-Magne F; Grabli D; Klebe S; Mangone G; You H; Mesnage V; Brice A; Vidailhet M; Corvol JC; Elbaz A;
Mov Disord; 2019 Nov; 34(11):1663-1671. PubMed ID: 31518456
[TBL] [Abstract][Full Text] [Related]
20. Prediction of depression and anxiety via patient-assessed tremor severity, not physician-reported motor symptom severity, in patients with Parkinson's disease or essential tremor who have undergone deep brain stimulation.
Achey RL; Yamamoto E; Sexton D; Hammer C; Lee BS; Butler RS; Thompson NR; Nagel SJ; Machado AG; Lobel DA
J Neurosurg; 2018 Dec; 129(6):1562-1571. PubMed ID: 29473781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
